BPC
AMPH icon

Banque Pictet & Cie’s Amphastar Pharmaceuticals AMPH Stock Holding History

Banque Pictet & Cie’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,073
Closed -$152K – 468
2014
Q4 		$152K Buy
+13,073
New +$142K ﹤0.01% 440

Other funds holding AMPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Banque Pictet & Cie's AMPH Position: Q1 2015 in Review

Banque Pictet & Cie sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2015, closing a stake of 13,073 shares — an estimated $152K sold.

Banque Pictet & Cie first reported a position in AMPH in Q4 2014 and held it in 1 quarter. The position peaked at $152K in Q4 2014. 59 funds tracked by Wall St. Rank hold AMPH as of Q1 2015.

  • Banque Pictet & Cie reported no remaining Amphastar Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Banque Pictet & Cie sold 13,073 Amphastar Pharmaceuticals shares in Q1 2015, an estimated $152K.
  • Banque Pictet & Cie first reported a position in Amphastar Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Banque Pictet & Cie's Amphastar Pharmaceuticals position peaked at $152K in Q4 2014.
  • 59 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2015.

Based on Banque Pictet & Cie's 13F filing for Q1 2015, filed 8 May 2015.